Workflow
多瑞医药:股票继续停牌,预计停牌时间不超过3个交易日

Core Points - Duori Pharmaceutical (301075.SZ) is actively advancing its transaction discussions, with no formal agreement signed yet [1] - The company anticipates that it will not resume trading on October 9, 2025, due to uncertainties surrounding the transaction [1] - To ensure fair information disclosure and protect investor interests, the company has applied for a continued trading suspension, expected to last no more than three trading days [1]